SKI Market

Indian Indices

Sensex

85,762.01 573.41
( 0.67%)

Global Indices

Nasdaq

48,397.51 313.23
(0.65%)

Dow Jones

6,878.71 12.21
(0.18%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,967.75 36.37
(0.37%)

Forex

USD-INR

89.87 0.03
(0.03%)

EUR-INR

105.50 -0.18
(-0.17%)

GBP-INR

120.91 -0.28
(-0.23%)

JPY-INR

0.57 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

62.7662681

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

15.63

115.73

EPS(TTM)

Face Value()

Div & Yield %

4.65

1.65

Back

&hra sugars ltd

Board of MRF recommends interim dividend

Nov 14,2025

MRF announced that the Board of Directors of the Company at its meeting held on 14 November 2025, inter alia, have recommended the interim dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

85,762.01 573.41 ( 0.67%)

48,397.51 313.23 (0.65%)

6,878.71 12.21 (0.18%)

50,384.39 -142.53 (-0.28%)

9,967.75 36.37 (0.37%)

89.87 0.03 (0.03%)

105.50 -0.18 (-0.17%)

120.91 -0.28 (-0.23%)

0.57 0.00 (-0.26%)